OBIO
Orchestra BioMed Holdings, Inc.
$3.65
-0.04 (-1.08%)
At close · Jul 15
Market Cap
$222.76M
Shares
59,880,715
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$3.65
Open$3.70
Day$3.63–3.82
52W$2.20–5.42
Avg vol 30d404K
Short int2.2M · 3.7% float · 2.7d
Short vol74%
DataAug 2020–Jul 2026
Filing10-Q · May 12
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 12, 2026
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 16.7 · calm
Equity put/call 0.67
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−11%
below
Price vs 50-day avg
−9%
below
RSI (14)
38
neutral
MACD trend
Negative
52-week position
45%
mid-range
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−9%
trailing
6-month return
−11%
trailing
YTD return
−12%
this year
Relative strength
−21%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $4 › 200d $4 — 200d above 50d
Institutional flow
Accumulating
3 of 65 funds reported for Jun 30 · net +43.5K sh shares · +1 new
Insider flow
Accumulating
Net +$99.9K over 90 days · 40% sells
Short interest
Rising
3.71% of float · ▲ +79.5% MoM · 2.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
65 holders — near 3-yr high, broad support
Squeeze score
54
elevated · 0–100
Fundamentals
Revenue growth
+1169%
Y/Y
EPS growth
+33%
Y/Y
Free cash flow
$-49.5M
Balance sheet
$19.7M
net cash
Quant / Vol
risk profile
Volatility
72%
annualized · 1-yr
Max drawdown
−35%
past year
ATR
6.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−11%
Bearish
Price vs 50-day avg
−9%
Bearish
RSI (14)
38
Neutral
MACD trend
Negative
Bearish
52-week position
45%
Neutral
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $4 › 200d $4 — 200d above 50d
Institutional flow
Accumulating
3 of 65 funds reported for Jun 30 · net +43.5K sh shares · +1 new
Insider flow
Accumulating
Net +$99.9K over 90 days · 40% sells
Short interest
Rising
3.71% of float · ▲ +79.5% MoM · 2.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
65 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $2
Now $4 · 45%
52-wk high $5
vs 200-day avg -11%
vs 50-day avg -9%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
OBIO
this stock
Orchestra BioMed Holdings, Inc.
|
$222.76M | -12.0% | +1169.2% | — | 3.7% |
|
ONC
BeOne Medicines Ltd.
|
$458.76B | +2.5% | +22179.2% | 933.6 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$123.36B | +5.2% | +46.2% | 28.8 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$71.18B | -13.8% | +20.8% | 16.6 | 3.3% |
|
ARGX
Argenx SE
|
$53.68B | +2.0% | — | — | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| OBIO | -6.9% | -9.2% | -10.8% | -15.4% | -12.1% |
| SPY | +1.3% | -0.2% | +10.1% | +1.1% | +10.7% |
| vs SPY | -8.2% | -9.0% | -20.9% | -16.5% | -22.7% |